Expensive blood safety initiatives may offer less benefit than we think

Transfusion

Volumn 50, Issue 1, 2010, Pages 240-242

  Kamper Jørgensen, Mads ^a,b,c,d   Hjalgrim, Henrik ^a,b,c,d   Edgren, Gustaf ^a,b,c,d   Titlestad, Kjell ^a,b,c,d   Ullum, Henrik ^a,b,c,d   Shanwell, Agneta ^a,b,c,d   Reilly, Marie ^a,b,c,d   Melbye, Mads ^a,b,c,d   Nyrén, Olof ^a,b,c,d   Rostgaard, Klaus ^a,b,c,d  

^a STATENS SERUM INSTITUT   (Denmark)

^b ODENSE UNIVERSITY HOSPITAL   (Denmark)

^c Mental Health Services CPH   (Denmark)

^d KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BLOOD DONOR; BLOOD TRANSFUSION; CASE REPORT; COST EFFECTIVENESS ANALYSIS; FOLLOW UP; HEALTH SERVICE; HUMAN; QUALITY ADJUSTED LIFE YEAR; RECIPIENT; SAFETY; SCREENING;

BLOOD BANKS; BLOOD TRANSFUSION; COST-BENEFIT ANALYSIS; FOLLOW-UP STUDIES; HUMANS; INFECTION; INFECTION CONTROL; QUALITY OF HEALTH CARE; QUALITY-ADJUSTED LIFE YEARS; RISK FACTORS; SCANDINAVIA; SURVIVAL ANALYSIS;

EID: 73649103470     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2009.02374.x     Document Type: Article

References (8)

1. Jackson BR, Busch MP, Stramer SL, AuBuchon JP. The cost-effectiveness of NAT for HIV, HCV, and HBV in whole-blood donations. Transfusion 2003 43 : 721 9.
2. Kleinman S, Marshall D, AuBuchon J, Patton M. Survival after transfusion as assessed in a large multistate US cohort. Transfusion 2004 44 : 386 90.
3. Vamvakas EC, Taswell HF Long-term survival after blood transfusion. Transfusion 1994 34 : 471 7.
4. Grima D, Marshall D, Kleinman S, AuBuchon J, Kulin N, Cheng R. Survival rates for patients receiving transfusions in the United States from an administrative managed care database abstract Value Health 2002 5 : 144.
5. Custer B, Busch MP, Marfin AA, Petersen LR The cost-effectiveness of screening the U.S. blood supply for West Nile virus. Ann Intern Med 2005 143 : 486 92.
6. Marshall DA, Kleinman SH, Wong JB, AuBuchon JP, Grima DT, Kulin NA, Weinstein MC. Cost-effectiveness of nucleic acid test screening of volunteer blood donations for hepatitis B, hepatitis C and human immunodeficiency virus in the United States. Vox Sang 2004 86 : 28 40.
7. Kamper-Jørgensen M, Ahlgren M, Rostgaard K, Melbye M, Edgren G, Nyrén O, Reilly M, Norda R, Titlestad K, Tynell E, Hjalgrim H. Survival after blood transfusion. Transfusion 2008 48 : 2577 84.
8. Edgren G, Hjalgrim H, Tran TN, Rostgaard K, Shanwell A, Titlestad K, Jakobsson L, Gridley G, Wideroff L, Jersild C, Adami J, Melbye M, Reilly M, Nyrén O. A population-based binational register for monitoring long-term outcome and possible disease concordance among blood donors and recipients. Vox Sang 2006 91 : 316 23.